BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

252 related articles for article (PubMed ID: 37076758)

  • 1. Unmet needs on the current medical management of Cushing's syndrome: results from a Delphi panel of Italian endocrinologists.
    Pivonello R; Scaroni C; Polistena B; Migliore A; Giustina A
    J Endocrinol Invest; 2023 Sep; 46(9):1923-1934. PubMed ID: 37076758
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A medical chart audit to assess endocrinologist perceptions of the burden of endogenous Cushing's syndrome.
    Page-Wilson G; Oak B; Silber A; Meyer J; O'Hara M; Geer EB
    Pituitary; 2024 Apr; 27(2):129-140. PubMed ID: 38189862
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Updates on the role of adrenal steroidogenesis inhibitors in Cushing's syndrome: a focus on novel therapies.
    Fleseriu M; Castinetti F
    Pituitary; 2016 Dec; 19(6):643-653. PubMed ID: 27600150
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Diagnosis and management of Cushing's syndrome: results of an Italian multicentre study. Study Group of the Italian Society of Endocrinology on the Pathophysiology of the Hypothalamic-Pituitary-Adrenal Axis.
    Invitti C; Pecori Giraldi F; de Martin M; Cavagnini F
    J Clin Endocrinol Metab; 1999 Feb; 84(2):440-8. PubMed ID: 10022398
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Bilateral adrenalectomy in the 21st century: when to use it for hypercortisolism?
    Guerin C; Taieb D; Treglia G; Brue T; Lacroix A; Sebag F; Castinetti F
    Endocr Relat Cancer; 2016 Feb; 23(2):R131-42. PubMed ID: 26739832
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Updates in adrenal steroidogenesis inhibitors for Cushing's syndrome - A practical guide.
    Varlamov EV; Han AJ; Fleseriu M
    Best Pract Res Clin Endocrinol Metab; 2021 Jan; 35(1):101490. PubMed ID: 33707082
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Treatment of adrenocorticotropin-dependent Cushing's syndrome: a consensus statement.
    Biller BM; Grossman AB; Stewart PM; Melmed S; Bertagna X; Bertherat J; Buchfelder M; Colao A; Hermus AR; Hofland LJ; Klibanski A; Lacroix A; Lindsay JR; Newell-Price J; Nieman LK; Petersenn S; Sonino N; Stalla GK; Swearingen B; Vance ML; Wass JA; Boscaro M
    J Clin Endocrinol Metab; 2008 Jul; 93(7):2454-62. PubMed ID: 18413427
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Treatment of Cushing's syndrome with osilodrostat: practical applications of recent studies with case examples.
    Fleseriu M; Biller BMK
    Pituitary; 2022 Dec; 25(6):795-809. PubMed ID: 36002784
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The dopaminergic control of Cushing's syndrome.
    Pivonello R; Pivonello C; Simeoli C; De Martino MC; Colao A
    J Endocrinol Invest; 2022 Jul; 45(7):1297-1315. PubMed ID: 35460460
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Assessment of cortisol and ACTH responses to the desmopressin test in patients with Cushing's syndrome and simple obesity.
    Tsagarakis S; Vasiliou V; Kokkoris P; Stavropoulos G; Thalassinos N
    Clin Endocrinol (Oxf); 1999 Oct; 51(4):473-7. PubMed ID: 10583315
    [TBL] [Abstract][Full Text] [Related]  

  • 11. PRKAR1A-negative familial Cushing's syndrome: two case reports.
    Lim LL; Kitan N; Paramasivam SS; Ratnasingam J; Ibrahim L; Chan SP; Tan AT; Vethakkan SR
    J Med Case Rep; 2015 Dec; 9():277. PubMed ID: 26619967
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Classic and recent etiologies of Cushing's syndrome: diagnosis and therapy.
    Beauregard C; Dickstein G; Lacroix A
    Treat Endocrinol; 2002; 1(2):79-94. PubMed ID: 15765624
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Paediatric Cushing's syndrome: epidemiology, investigation and therapeutic advances.
    Storr HL; Chan LF; Grossman AB; Savage MO
    Trends Endocrinol Metab; 2007; 18(4):167-74. PubMed ID: 17412607
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A New Clinical Model to Estimate the Pre-Test Probability of Cushing's Syndrome: The Cushing Score.
    Parasiliti-Caprino M; Bioletto F; Frigerio T; D'Angelo V; Ceccato F; Ferraù F; Ferrigno R; Minnetti M; Scaroni C; Cannavò S; Pivonello R; Isidori A; Broglio F; Giordano R; Spinello M; Grottoli S; Arvat E
    Front Endocrinol (Lausanne); 2021; 12():747549. PubMed ID: 34675882
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Medical Treatment of Cushing's Disease: An Overview of the Current and Recent Clinical Trials.
    Pivonello R; Ferrigno R; De Martino MC; Simeoli C; Di Paola N; Pivonello C; Barba L; Negri M; De Angelis C; Colao A
    Front Endocrinol (Lausanne); 2020; 11():648. PubMed ID: 33363514
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cushing's syndrome: an update on current pharmacotherapy and future directions.
    Creemers SG; Hofland LJ; Lamberts SW; Feelders RA
    Expert Opin Pharmacother; 2015; 16(12):1829-44. PubMed ID: 26133755
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Work-up and management of paediatric Cushing's syndrome.
    Savage MO; Chan LF; Grossman AB; Storr HL
    Curr Opin Endocrinol Diabetes Obes; 2008 Aug; 15(4):346-51. PubMed ID: 18594275
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Management of hypercortisolism].
    Rosales C; Fierrard H; Bertagna X; Raffin-Sanson ML
    Rev Med Interne; 2008 Apr; 29(4):337-46. PubMed ID: 18226430
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cushing's disease: adrenal steroidogenesis inhibitors.
    Pivonello R; Simeoli C; Di Paola N; Colao A
    Pituitary; 2022 Oct; 25(5):726-732. PubMed ID: 36036308
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Quality of life in Cushing's syndrome.
    Bride MM; Crespo I; Webb SM; Valassi E
    Best Pract Res Clin Endocrinol Metab; 2021 Jan; 35(1):101505. PubMed ID: 33707083
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.